Skip directly to content

Pfizer sponsors Science Museum exhibition "Superbugs: The Fight for Our Lives"

We're sponsoring a new exhibition which explores the growing threat of antibiotic resistance – a global challenge, that matters to us all.

 

Antibiotics have revolutionised how we treat infectious disease.1 Some of us might require an antibiotic at some point in our lives, and many medical interventions depend on them.2

But some bacteria are now becoming resistant to antibiotics. Some of these resistant bacteria are referred to as ‘Superbugs’.3

Without action, important operations and common illnesses could become life-threatening;4 it is predicted that antimicrobial resistance could potentially impact millions of lives by 2050 without greater intervention.5

 

"Superbugs: the Fight for our Lives"

To help raise the public’s awareness of this complex issue, Pfizer has sponsored a new exhibition at the Science Museum, called "Superbugs: The Fight for Our Lives".

The exhibition highlights the role that we all have to play in this fight – from pharmaceutical companies to governments, healthcare professionals, and the public.

Visitors will get to see real bacteria up close, including nine so called ‘superbugs’ that the World Health Organisation classifies as a significant threat to human health.

They can also learn more about the people on the front line in the fight against superbugs, from a patient who has contacted an infection resistant to antibiotics to healthcare professionals preventing infections, and a designer’s solution to stop bacteria spreading.

 

Pfizer’s work in infectious diseases

Since Pfizer successfully mass produced penicillin (in the UK) during the 1950s,6 we have been actively engaged in the research and development of innovative medicines, and the development of policies and educational programmes to address the ever evolving challenges in infectious diseases.7

 

References

  1. Dr Diane Ashiru-Oredope. (2015). Antibiotic Resistance: why the fuss and what simple actions can everyone take? Available at: https://longitudeprize.org/blog-post/antibiotic-resistance-why-fuss-and-what-simple-actions-can-everyone-take [Last accessed November 2017]
  2. Public Health England. Health matters: antimicrobial resistance. Published 10 December 2015. Available at: https://www.gov.uk/government/publications/health-matters-antimicrobial-resistance/health-matters-antimicrobial-resistance [Last accessed November 2017]
  3. World Health Organisation – Health Topics – Antimicrobial Resistance. Available at: http://www.who.int/topics/antimicrobial_resistance/en/ [Last accessed November 2017]
  4. World Health Organisation, Antimicrobial resistance Fact sheet - Updated October 2017. Available at: http://www.who.int/mediacentre/factsheets/fs194/en/ [Last accessed November 2017]
  5. The Review on Antimicrobial Resistance. Tackling Drug-Resistant Infections Globally: Final Report and Recommendations. Chaired by Jim O’Neill. May 2016.  Available at: https://amr-review.org/sites/default/files/160525_Final%20paper_with%20cover.pdf
  6. Pfizer. Our history. https://www.pfizer.co.uk/content/our-history  [Last accessed November 2017]
  7. Pfizer 2016 Annual Review. Available at: https://www.pfizer.com/files/investors/financial_reports/annual_reports/2016/our-business/global-businesses/pfizer-essential-health/index.html  [Last accessed November 2017]

     

PP-PFE-GBR-0766 / Nov 2017